Dose control technology used in FIB implantation is quite similar to that
applied to standard implantation. Current technology is such that dose
control is much more of a solved problem than characterization. Thus, most
commercial FIB implanters include dose controllers that rely on the same
basic principles. After passing through the column, the ion beam is ideally
free of neutral particles and uniform in composition. Standard dose con-
trollers thus begin with a measurement of the instantaneous electric current
flowing in the sample. This current is almost entirely due to the flux of ions
into the substrate. The current measurements are summed by an integrator
and converted to a dose value under the assumption that all the incident ions
carry the same charge. This assumption holds well when the beamline
(the space through which the ion beam travels) is maintained at a good
vacuum pressure. Otherwise, the ions will collide with residual gas molecules
in the beamline and either lose or gain electrons, affecting their response to
electric and magnetic fields. A net neutralization or charge exchange of ions
in the beamline will cause the actual implanted dose to differ from the dose
calculated by integration of the current. However, beamline vacuums of
5 · 10
7
torr or less can easily be achieved today, while techniques exist to
compensate for dose error at up to 5 · 10
4
torr [5]. Thus, the uniform current
assumption is valid for all purposes. Alternatively, the integrator can be
excluded to obtain the instantaneous dose rate. These measurements can then
be sent into a feedback loop to regulate the dose rate and thus the total dose.
Furthermore, if the size and position of the beam are known, these mea-
surements can also be used to produce a map of the dose applied to each
beam-sized pixel of the substrate. This is the basis behind patterned
implantation using FIBs. In practice, it is often inadvisable to measure the
current directly on the substrate. Thus many modern implanters monitor the
ion beam using Faraday cups independent of the substrate [6,7].
A complete characterization of the dose in an implanted sample consists of a
three-dimensional map of the concentration of impurity ions throughout it. As
described above, after implantation is complete the dose controller is capable
of outputting a planar map of the total dose applied to each beam-sized pixel
of the substrate. In addition to completely ignoring the vertical impurity dis-
tribution, this does not take into account the random horizontal scattering of
ions. Evidently, the information available from the dose controller is insuffi-
cient to determine if an implantation step has met a set of specifications to
within appropriate tolerances. Consequently, post-processing for implanted
substrates must include a characterization step to determine the actual spatial
ion distribution resulting from implantation.
Focused ion beam systems320